{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:45:45Z","timestamp":1787071545740,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>SARS-CoV-2 vaccination (SC2V) can be complicated by post-acute COVID-19 vaccination syndrome (PACVS). One manifestation of PACVS is small fibre neuropathy (SFN). A positive effect of intravenous immunoglobulins (IVIGs) even 3 years after the onset of PACVS is not known. The patient is a 52-year-old woman who developed PACVS after the second BNT162b2 vaccination in June 2021, which manifested clinically with SFN, myopericarditis, coagulopathy, and ocular, dermatologic, immunologic, and central nervous system (CNS) abnormalities. The SFN itself manifested as sensory disturbances, arterial hypotension and postural tachycardia syndrome (POTS). After the patient received three cycles of IVIGs, starting in June 2024, three years after the onset of PACVS, there was a significant positive effect on her SFN and other symptoms, as evidenced by various specific investigations. This case demonstrates that symptoms and signs of SFN as a manifestation of PACVS may benefit from the administration of IVIGs even years after onset.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_325_25","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:01:25Z","timestamp":1764327685000},"page":"4915-4919","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Immunoglobulins are beneficial in SARS-CoV-2 vaccine-induced small fibre neuropathy even 3 years after onset"],"prefix":"10.4103","volume":"14","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[{"name":"Department of Beurology, Neurology and Neurophysiology Center, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"R1-20251211","doi-asserted-by":"crossref","first-page":"154","DOI":"10.14712\/18059694.2024.10","article-title":"Self-reported side effects of SARS-CoV-2 vaccination","volume":"66","author":"Finsterer","year":"2023","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"R2-20251211","doi-asserted-by":"crossref","first-page":"222","DOI":"10.9758\/cpn.2023.21.2.222","article-title":"Neurological adverse reactions to SARS-CoV-2 vaccines","volume":"21","author":"Finsterer","year":"2023","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R3-20251211","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ane.13591","article-title":"Small fibre neuropathy","volume":"145","author":"Finsterer","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"R4-20251211","doi-asserted-by":"crossref","first-page":"100304","DOI":"10.1016\/j.clinsp.2023.100304","article-title":"SARS-CoV-2 vaccination complicated by small fibre neuropathy, mast cell activation syndrome, and pericarditis","volume":"78","author":"Hertz","year":"2023","journal-title":"Clinics (Sao Paulo)"},{"key":"R5-20251211","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.4103\/jfmpc.jfmpc_2394_21","article-title":"Small fibre neuropathy as a complication of SARS-CoV-2 vaccinations","volume":"11","author":"Finsterer","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"R6-20251211","doi-asserted-by":"crossref","first-page":"104441.158","DOI":"10.1016\/j.nmd.2024.07.167","article-title":"567P A prospective observational study on the effect of intravenous immunoglobulin on small fibre neuropathy after SARS-CoV-2 infection or vaccination","volume":"43","author":"Shin","year":"2024","journal-title":"Neuromuscul Disord"},{"key":"R7-20251211","first-page":"e55205","article-title":"Myocarditis, coagulopathy, and small fibre, sensory, and multiple cranial nerve neuropathy complicating BNT162b2 vaccination:A case report","volume":"16","author":"Finsterer","year":"2024","journal-title":"Cureus"},{"key":"R8-20251211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CND.0000000000000485","article-title":"Effectiveness of IVIG on non-length-dependent skin biopsies in small fiber neuropathy with plexin D1, trisulfated heparin disaccharide, and fibroblast growth factor receptor 3 autoantibodies","volume":"25","author":"Zeidman","year":"2024","journal-title":"J Clin Neuromuscul Dis"},{"key":"R9-20251211","doi-asserted-by":"crossref","first-page":"2215153","DOI":"10.1080\/21645515.2023.2215153","article-title":"Progress in Guillain-Barre syndrome immunotherapy \u2013A narrative review of new strategies in recent years","volume":"19","author":"Yao","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"R10-20251211","doi-asserted-by":"crossref","first-page":"e200244","DOI":"10.1212\/NXI.0000000000200244","article-title":"Case-control study of individuals with small fiber neuropathy after COVID-19","volume":"11","author":"McAlpine","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R11-20251211","article-title":"Analysis of 977 long COVID patients reveals prevalent neuropathy and association with anti-ganglioside antibodies","author":"Maguire","year":"2025","journal-title":"medRxiv"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_325_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:47:57Z","timestamp":1787068077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_325_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_325_25","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"2025-02-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}